A Phase III Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women with Node-Positive or High Risk Node Negative, HER2-Negative Breast Cancer(B-46-I)-scope of 3048105106

No abstract available.

Status	Finished
Effective start/end date	2/4/10 → 8/31/19

NSABP Master Agreement (TIND)
Chambers, M. (PI), Mathew, A. (Former PI) & Romond, E. (Former PI)
NSABP Foundation
2/1/98 → 5/12/25
Project: Research project

Grants and Contracts Details